Transamidation by transglutaminase 2 transforms S100A11 calgranulin into a procatabolic cytokine for chondrocytes

Journal of Immunology

Volumn 180, Issue 12, 2008, Pages 8378-8385

  Cecil, Denise L ^a   Terkeltaub, Robert ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; AGGRECANASE; CALGRANULIN; CYTOKINE; GLYCOSAMINOGLYCAN; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; PROTEIN S 100; PROTEIN S100A11; UNCLASSIFIED DRUG; AMIDE; GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; RAGE PROTEIN, MOUSE; S100A11 PROTEIN, HUMAN; S100A11 PROTEIN, MOUSE; TRANSGLUTAMINASE 2;

AMIDATION; ANIMAL CELL; ARTICLE; CARTILAGE CELL; CATABOLISM; CONTROLLED STUDY; EXPLANT; FEMUR HEAD; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; SIGNAL TRANSDUCTION; AMINO ACID SEQUENCE; ANIMAL; ARTICULAR CARTILAGE; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; CELL LINE; ENZYMOLOGY; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; MOUSE MUTANT; ORGAN CULTURE TECHNIQUE; OSTEOARTHRITIS; PATHOLOGY; PHYSIOLOGY;

AMIDES; AMINO ACID SEQUENCE; ANIMALS; CARTILAGE, ARTICULAR; CELL DIFFERENTIATION; CELL LINE, TRANSFORMED; CELLS, CULTURED; CHONDROCYTES; CYTOKINES; GTP-BINDING PROTEINS; HUMANS; LEUKOCYTE L1 ANTIGEN COMPLEX; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASES; MOLECULAR SEQUENCE DATA; ORGAN CULTURE TECHNIQUES; OSTEOARTHRITIS; S100 PROTEINS; TRANSGLUTAMINASES;

EID: 50949122078     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.12.8378     Document Type: Article

References (55)

1. Goldring, S. R., and M. B. Goldring. 2004. The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin. Orthop. Relal. Res. (427 Suppl.): S27-S36.
2. Farahat, M. N., G. Yanni, R. Poston, and G. S. Panayi. 1993. Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis. Ann. Rheum. Dis. 52: 870-875.
3. Schlaak, J. F., I. Pfers, K. H. Meyer Zum Büschenfelde, and E. Märker-Hermann. 1996. Different cytokine profiles in the synovial fluid of patients with osteoarthritis, rheumatoid arthritis and seronegative spondylarthropathies. Clin. Exp. Rheumatol. 14: 155-162.
4. Glasson, S. S., R. Askew, B. Sheppard, B. Carito, T. Blanchet, H. L. Ma, C. R. Flannery, D. Peluso, K. Kanki, Z. Yang, et al. 2005. Deletion of active ADAMTS-5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 434: 644-648.
5. Melchiorri, C., R. Meliconi, L. Frizziero, T. Silvestri, L. Pulsatelli, I. Mazzetti, R. M. Borzi, M. Uguccioni, and A. Facchini. 1998. Enhanced and coordinated in vivo expression of inflammatory cytokines and nitric oxide synthase by chondrocytes from patients with osteoarthritis. Arthritis Rheum. 41: 2165-2174.
6. Borzi, R. M., I. Mazzetti, S. Macor, T. Silvestri, A. Bassi, L. Cattini, and A. Facchini. 1999. Flow cytometric analysis of intracellular chemokines in chondrocytes in vivo: constitutive expression and enhancement in osteoarthritis and rheumatoid arthritis. FEBS Lett. 455: 238-242.
7. Nurminskaya, M., and T. F. Linsenmayer. 1996. Identification and characterization of up-regulated genes during chondrocyle hypertrophy. Dev. Dyn. 206: 260-271.
8. Merz, D., R. Liu, K. Johnson, and R. Terkeltaub. 2003. IL-8/CXCL8 and growth-related oncogeneα/CXCL1 induce chondrocyte hypertrophic differentiation. J. Immunol. 171: 4406-4415.
9. Terkeltaub, R. A. 2002. What does cartilage calcification tell us about osteoarthritis? J. Rheumatol. 29: 411-415.
10. Chen, Q., D. M. Johnson, D. R. Haudenschild, and P. F. Goetinck. 1995. Progression and recapitulation of the chondrocyte differentiation program: cartilage matrix protein is a marker for cartilage maturation. Dev. Biol. 172: 293-306.
11. Kirsch, T., B. Swoboda, and H. Nah. 2000. Activation of annexin II and V expression, terminal differentiation, mineralization and apoptosis in human osteoarthritic cartilage. Osteoarthritis Cartilage 8: 294-302.
12. Kamekura, S., Y. Kawasaki, K. Hoshi, T. Shimoaka, H. Chikuda, Z. Maruyama, T. Komori S. Sato, S. Takeda, G. Karsenty, et al. 2006. Contribution of runtrelated transcription factor 2 to the pathogenesis of osteoarthritis in mice after induction of knee joint instability. Arthritis Rheum. 54: 2462-2470.
13. Pelletier, J. P., J. Martel-Pelletier, and S. B. Abramson. 2001. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum. 44: 1237-1247.
14. Goldring, M. B. 2001. Antieytokine therapy for osteoarthritis. Expert Opin. Biol. Ther. 1:817-829.
15. Attur, M. G., M. N. Dave, M. Y. Leung, C. Cipolletta, M. Meseck, S. L. Woo, and A. R. Amin. 2002. Functional genomic analysis of type II IL-1β decoy receptor: potential for gene therapy in human arthritis and inflammation. J. Immunol. 168: 2001-2010.
16. Donato, R. 2001. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell Biol. 33: 637-668.
17. Manitz, M. P., B. Horst, S. Seeliger, A. Strey, B. V. Skryabin, M. Gunzer, W. Frings, F. Schonlau, J. Roth, C. Sorg, and W. Nacken. 2003. Loss of S100A9 (MRP14) results in reduced interleukin-8-induced CD11b surface expression, a polarized microfilament system, and diminished responsiveness to chemoattractants in vitro. Mol. Cell Biol. 23: 1034-1043.
18. Viemann, D., A. Strey, A. Janning, K. Jurk, K. Klimmek, T. Vogl, K. Hirono, F. Ichida, D. Foell, B. Kehrel, et al. 2005. Myeloid-related proteins 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells. Blood 105: 2955-2962.
19. Cecil, D. L., K. Johnson, J. Rediske, M. Lotz, A. M. Schmidt, and R. Terkeltaub. 2005. Inflammation-induced chondrocyte hypertrophy is driven by receptor for advanced glycation end products. J. Immunol. 175: 8296-8302.
20. Yammani, R. R., C. S. Carlson, A. R. Bresnick, and R. F. Loeser. 2006. Increase in production of matrix metalloproteinase 13 by human articular chondrocytes due to stimulation with S100A4: role of the receptor for advanced glycation end products. Arthritis Rheum. 54: 2901-2911.
21. Loeser, R. F., R. R. Yammani, C. S. Carlson, H. Chen, A. Cole, H. J. Im, L. S. Bursch, and S. D. Yan. 2005. Articular chondrocytes express the receptor for advanced glycation end products: potential role in osteoarthritis. Arthritis Rheum. 52: 2376-2385.
22. Bucciarelli, L. G., T. Wendt, L. Rong, E. Lalla, M. A. Hofmann, M. T. Goova, A. Taguchi, S. F. Yan, S. D. Yan, D. M Stern, and A. M. Schmidt. 2002. RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease. Cell Mol. Life Sci. 59: 1117-1128.
23. Alikhani, M., Z. Alikhani, C. Boyd, C. M. MacLellan, M. Raptis, R. Liu, N. Pischon, P. C. Trackman, L. Gerstenfeld, and D. T. Graves. 2007. Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways. Bone 40: 345-353.
24. Orlova, V. V., E. Y. Choi, C. Xie, E. Chavakis, A. Bierhaus, E. Ihanus, C. M, Ballantyne, C. G. Gahmberg, M. E. Bianchi, P. P. Nawroth, and T. Chavakis. 2007. A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin. EMBO J. 26: 1129-1139.
25. Huang, J. S., J. Y. Guh, H. C. Chen, W. C. Hung, Y. H. Lai, and L. Y. Chuang. 2001. Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells. J. Cell Biochem. 81: 102-113.
26. Barger, S. W., S. R. Wolchok, and L. J. Van Eldik. 1992. Disulfide-linked S100 beta dimers and signal transduction. Biochim. Biophys. Acta 1160: 105-112.
27. Moroz, O. V., A. A. Antson, E. J. Dodson, H. J. Burrell, S. J. Grist, R. M. Lloyd, N. J. Maitland, G. G. Dodson, K. S. Wilson, E. Lukanidin, and I. B. Bronstein. 2002. The structure of S100A12 in a hexameric form and its proposed role in receptor signalling. Acta Crystallogr. D. Biol. Crystallogr. 58(Pt. 3): 407-413.
28. Novitskaya, V., M. Grigorian, M. Kriajevska, S. Tarabykina, I. Bronstein, V. Berezin, E. Bock, and E. Lukanidin. 2000. Oligomeric forms of the metastasis related Mts1 (S100A4) protein stimulate neuronal differentiation in cultures of rat hippocampal neurons. J. Biol. Chem. 275: 41278-41286.
29. Lorand, L., and R. M. Graham. 2003. Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat. Rev. Mol. Cell Biol. 4: 140-156.
30. Ruse, M., A. Lambert, N. Robinson, D. Ryan, K. J. Shon, and R. L. Eckert. 2001. S100A7, S100A10, and S100A11 are transglutaminase substrates. Biochemistry 40: 3167-3173.
31. Aeschlimann, D., D. Mosher, and M. Paulsson. 1996. Tissue transglutaminase and factor XIII in cartilage and bone remodeling. Semin. Thromb. Hemost. 22: 437-443.
32. Rosenthal, A. K., C. M. Gohr, M. Uzuki, and I. Masuda. 2006. Osteopontin promotes pathologic mineralization in articular cartilage. Matrix Biol. 26: 96-105.
33. Johnson, K., S. Hashimoto, M. Lotz, K. Pritzker, and R. Terkeltaub. 2001. In-terleukin-1 induces pro-mineralizing activity of cartilage tissue transglutaminase and factor XIIIa. Am. J. Pathol. 159: 149-163.
34. Summey, B. T. Jr., R. D. Graff, T. S. Lai, C. S. Greeberg, and G. M. Lee. 2002. Tissue transglutaminase localization and activity regulation in the extracellular matrix of articular cartilage. J. Orthop. Res. 20: 76-82.
35. Johnson, K. A., D. van Etten, N. Nanda, R. M. Graham, and R. A. Terkeltaub. 2003. Distinct transglutaminase 2-independent and transglutaminase 2-dependent pathways mediate articular chondrocyle hypertrophy. J. Biol. Chem. 278: 18824-18832.
36. Johnson, K. A., and R. A. Terkeltaub. 2005. External GTP-bound transglutaminase 2 is a molecular switch for chondrocyte hypertrophic differentiation and calcification. J. Biol. Chem. 280: 15004-15012.
37. Matsui Lee, I. S., M. Suzuki, N. Ilayashi, J. Hu, L. J. Van Eldik, K. Titani, and M. Nishikimi. 2000. Copper-dependent formation of disulfide-linked dimer of S100B protein. Arch. Biochem. Biophys. 374: 137-141.
38. Farndale, R. W., C. A. Sayers, and A. J. Barrett. 1982. A direct spectrophoto-metric microassay for sulfated glycosaminoglycans in cartilage cultures. Connect Tissue Res. 9: 247-248.
39. Salvat, C., A. Pignet, L. Humbert, F. Bercnbaum, and S. Thirion. 2005. Immature murine articular chondrocytes in primary culture: a new tool for investigating cartilage. Osteoarthritis Cartilage 13: 243-249.
40. Chambers, M. G., T. Kuffner, S. K. Cowan, K. S. Cheah, and R. M. Mason. 2002. Expression of collagen and aggrccan genes in normal and osteoarthritic murine knee joints. Osteoarthritis Cartilage 10: 51-61.
41. Falasca, L., V. Iadevaia, F. Ciccosanti, G. Melino, A. Serafino, and M. Piaccntini. 2005. Transglulaminase type II is a key element in the regulation of the anti-inflammatory response elicited by apoptotic cell engulfment. J. Immunol. 174: 7330-7340.
42. Rety, S., J. Sopkova, M. Renouard, D. Osterloh, V. Gerke, S. Tabaries, F. Russo-Marie, and A. Lewit-Bentley. 1999. The crystal structure of a complex of pH with the annexin II N-terminal peptide. Nat. Struct. Biol. 6: 89-95.
43. Banner, D. W., A. D'Arcy, W. Janes, R. Gentz, H. J. Schoenfeld, C. Broger, H. Loetscher, and W. Lesslauer. 1993. Crystal structure of the soluble human 55 kd TNF receptor-human TNF B complex: implications for TNF receptor activation. Cell 73: 431-445.
44. Naismith, J. H., T. Q. Devine, T. Kohno, and S. R. Sprang. 1996. Structures of the extracellular domain of the type I tumor necrosis factor receptor. Structure 4: 1251-1262.
45. Bravo, J., and J. K. Heath. 2000. Receptor recognition by gpl30 cytokines. EMBOJ. 19:2399-2411.
46. Sugimura, Y., M. Hosono, F. Wada, T. Yoshimura, M. Maki, and K. Hitomi. 2006. Screening for the preferred substrate sequence of transglutaminase using a phage-displayed peptide library: identification of peptide substrates for TGASE 2 and Factor XIHA. J. Biol. Chem. 281: 17699-17706.
47. Kiryushko, D., V. Novitskaya, V. Soroka, J. Klingelhofer, E. Lukanindin, V. Berezin, and E. Bock. 2006. Molecular mechanisms of Ca2+ signaling in neurons induced by the S100A4 protein. Mol. Cell Biol. 26: 3625-3638.
48. Saleem, M., M. H. Kweon, J. J. Johnson, V. M. Adhami, I. Elcheva, N. Khan, B. Bin Hafeez, K. M. Bhat, S. Sarfaraz, S. Reagan-Shaw, et al. 2006. S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the Iranscriptional regulation of matrix metalloproteinase 9. Proc. Natl. Acad. Sci. USA 103: 14825-14830.
49. Winningham-Major, F., J. L. Staecker, S. W. Barger, S. Coats, and L. J. Van Eldik. 1989. Ncurite extension and neuronal survival activities of re-combinant S100 beta proteins that differ in the content and position of cysteine residues. J. Cell Biol. 109: 3063-3071.
50. Koppal, T., A. G. Lam, L. Guo, and L. J. Van Eldik. 2001. S100B proteins that lack one or both cysteine residues can induce inflammatory responses in astro-cytes and microglia. Neurochem. Int. 39: 401-407.
51. Ostendorp, T., E. Leclerc, A. Galichet, M. Koch, N. Demling, B. Weigle, C. W. Heizmann, P. M. Kroneck, and G. Fritz. 2007. Structural and functional insights into RAGE activation by multimeric S100B. EMBO J. 26: 3868-3878.
52. Leukert, N., T. Vogl, K. Strupat, R. Reichelt, C. Sorg, and J. Roth. 2006. Calcium-dependent tctramer formation of S100A8 and S100A9 is essential for biological activity. J. Mol. Biol. 359: 961-972.
53. Xie, J., D. S. Burz, W. He, I. B. Bronstein, I. Lednev, and A. Shekhtman. 2007. Hexameric calgranulin C (S100A12) binds to the receptor for advanced glycated end products (RAGE) using symmetric hydrophobic target-binding patches. J. Biol. Chem. 282: 4218-4231.
54. Amer, E. C. 2002. Aggrecanase-mediated cartilage degradation. Curr. Opin. Pharmacol. 2: 322-329.
55. Pulai, J. I., H. Chen, H. J. Im, S. Kumar, C. Hanning, P. S. Hegde, and R. F. Loeser. 2005. NF-KB mediates the stimulation of cytokine and chemokine expression by human articular chondrocytes in response to fibronectin fragments. J. Immunol. 174: 5781-5788.